Consorci Sanitari De Terrassa — Clinical Trial Site

27 Registered trials

11 Currently recruiting

Organisation

Consorci Sanitari De Terrassa

Location

Terrassa, Spain

Identifier

ORG-100044206

Address

Carretera Torrebonica Sn, 08227, Spain

Departments

724012: Ophthalmology
937231010
Allergology
Allergy
cirugia
Hematología
Internal medicine
Medical Oncology
Neurología
Neurology department
Obstetrician and Gynecologist
Oncology
Oncology Department
Orthopedic Surgery and Traumatology Service (Knee Unit)
Radiation Oncology
Servicio de digestivo
Servicio de Medicina Interna
Servicio de Oncología

Clinical trials at this site (27)

Search interface

“USE OF A FIBRIN ADHESIVE TO REDUCE ESOPHAGOYEJUNAL ANASTOMOSIS DEHISCENCE IN TOTAL GASTRECTOMIES FOR CANCER: RANDOMIZED AND MULTICENTER STU… Pending

2024-519529-40-00 ESOPHAGOYEJUNAL ANASTOMOSIS DEHISCENCE IN TOTAL GASTREC 5
FOSFOMYCIN AS AN ORAL ALTERNATIVE THERAPY IN THE TREATMENT OF ACUTE BACTERIAL PROSTATITIS CAUSED BY MULTIDRUG-RESISTANT ESCHERICHIA COLI. PI… Pending

2024-520012-18-00 Prostatitis aguda bacteriana (PAB) por Escherichia coli 6
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Allergic rhinoconjunctivitis to Dermatophagoides pteron 5
Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES) Pending

2025-521709-42-00 Allergic rhinoconjunctivitis with or without asthma due 5
Grass Immunotherapy for Rhinitis and Asthma (GIRA) Pending

2025-521736-10-00 Allergic rhinoconjunctivitis with or without controlled 5
Optimizing Aspirin Use for Preeclampsia Prevention Pending

2025-524646-94-00 Obstetrics – Preeclampsia 11
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of… Recruiting

2023-508547-51-00 Aetiological treatment of moderate-to-severe allergic r 5 2025-11-18
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting

2025-520613-31-00 Agitation Associated with Alzheimer’s Disease 5 2025-10-31
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Chronic migraine 5 2025-10-06
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Episodic migraine 5 2025-10-06
A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge… Recruiting

2023-509547-27-00 Geographic Atrophy Secondary to Age-Related Macular Deg 5 2025-05-22
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting

2024-515055-38-00 Adult patients undergoing TJR surgery. 5 2025-02-13
Study of treatment with sacituzumab and zimkberelimab for patients with lung cancer confined to the chest and previously operated on who wer… Recruiting

2024-512960-75-00 Resectable Non-small cell lung cancer 5 2025-02-04
Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis Recruiting

2024-519969-21-00 Infective endocarditis 6 2025-01-01
Fractionated stereotactic radiotherapy plus second-generation antiandrogen for oligometastatic patients with castration-resistant prostate c… Recruiting

2023-505024-62-01 Oligometastatic patients with castration-resistant pro 4 2024-05-16
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10
Trial of dostarlimab (TSR-042) for patients with high-risk locally advanced cervical cancer after chemo-radiation Ended

2023-510268-11-00 Cervical cancer 4 2019-06-11
Clinical trial to compare the efficacy of two treatment sequencing schemes with chemotherapy (the regime called FOLFOX and FOLFIRI) in combi… Ended

2024-510967-41-00 Metastatic colorectal cancer 5 2018-09-21
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 To determine whether the addition of palbociclib to adj 5 2015-10-27
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A large-scale comparative study evaluating an intravenous treatment, cabazitaxel, and radiation therapy to the pelvic lymph nodes in patient… Ended

2024-517622-25-00 Patients with localized prostate cancer and high-risk f 5 2013-12-06
Clinical trial developed at various hospitals where each patient randomly receive in parallel groups either placebo or treatment. Nor patien… Ended

2024-519527-14-00 Allergic rhinoconjunctivitis 5 2022-06-09